Results for plaveiselcel translation from Dutch to English

plaveiselcel
stratified squamous epithelium

metaplasie; plaveiselcel
metaplasia; squamous cell

plaveiselcel (n = 473)
squamous cell (n = 473)

plaveiselcel; metaplasie, blaas
squamous metaplasia of bladder

bovenkaak; tumor, odontogeen, plaveiselcel
upper jaw; tumor, odontogenic, squamous cell

odontogeen; tumor, plaveiselcel, bovenkaak (bot)
odontogenic; tumor, squamous cell, upper jaw (bone)

niet- invasieve spms omvatten basaalcel of plaveiselcel huidkankers.
non-invasive spm comprise basal cell or squamous cell skin cancers.

plaveiselcel nsclc met egfr-activerende mutaties, moet de vergunninghouder
squamous nsclc harbouring egfr activating mutations, the mah should

carcinoom; plaveiselcel, micro-invasief, niet gespecificeerde lokalisatie
carcinoma; squamous cell, microinvasive, unspecified site

eerstelijnsbehandeling van niet-plaveiselcel nsclc in combinatie met platinumbevattende chemotherapie
first-line treatment of non-squamous nsclc in combination with platinum-based chemotherapy

cervix; plaveiselcel carcinoma in situ, met dubieuze stroma-invasie
carcinoma in situ; cervix, squamous cell, with questionable stromal invasion

carcinoma in situ; cervix, plaveiselcel, met dubieuze stroma-invasie
carcinoma in situ; cervix, squamous cell, with questionable stromal invasion

carcinoma in situ; plaveiselcel, met dubieuze stroma-invasie, niet gespecificeerde lokalisatie
carcinoma in situ; squamous cell, with questionable stromal invasion, unspecified site

de enige variabelen die statistisch significante correlatie met bloedingen vertoonden zijn behandeling met avastin en plaveiselcel histologie.
the only variables that showed statistically significant correlations with bleeding were avastin therapy and squamous cell histology.

het potentieel effect van bevacizumab op de farmacokinetiek van cisplatine en gemcitabine is onderzocht bij patiënten met niet-plaveiselcel nsclc.
the potential effect of bevacizumab on the pharmacokinetics of cisplatin and gemcitabine was investigated in non-squamous nsclc patients.

verschillende gecontroleerde klinische studies waarbij epoëtines toegediend werden aan patiënten met verschillende veelvoorkomende tumoren zoals plaveiselcel hoofd- en halskanker, longkanker en borstkanker toonden een onverklaarde grotere mortaliteit.
several controlled clinical studies in which epoetins were administered to patients with a variety of common tumours including squamous head and neck cancer, lung cancer, and breast cancer, have shown an unexplained excess mortality.

randomisatie werd gestratificeerd naar eastern cooperative oncology group (ecog) status (0 versus 1), voorbehandeling met bevacizumab (ja versus nee), hersenmetastase (ja versus nee) en tumorhistologie (plaveiselcel- versus niet-plaveiselceltumorhistologie).
randomization was stratified according to eastern cooperative oncology group (ecog) status (0 versus 1), bevacizumab pretreatment (yes versus no), brain metastasis (yes versus no) and tumour histology (squamous versus non-squamous tumour histology).